Skip to main content

Table 2 Sex-specific distribution of breast lesions diagnosed by breast cytology

From: Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study

Cytological diagnoses Women Men Total
n (%) n (%) n (%)
A. Neoplastic  
Ductal carcinoma 63 (18 %) 5 (12.5 %) 68 (17.4 %)
Fibroadenoma 136 (38.9 %) 0 (0 %) 136 (34.9 %)
Fibrocystic changes 38 (10.9 %) 0 (0 %) 38 (9.7 %)
Benign breast lesion, NOS 19 (5.4 %) 1 (2.5 %) 20 (5.1 %)
Intraductal papilloma 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Lobular carcinoma 6 (1.7 %) 0 (0 %) 6 (1.5 %)
Malignant breast lesion 5 (1.4 %) 0 (0 %) 5 (1.3 %)
Suspicious for malignancy 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Fibroadenomatosis 2 (0.6 %) 0 (0 %) 2 (0.5 %)
Intraductal papilloma with fibrocystic changes 2 (0.6 %) 0 (0 %) 2 (0.5 %)
Fibroadenoma with granulomatous mastitis 1 (0.3 %) 0 (0 %) 1 (0.3 %)
Ductal hyperplasia 1 (0.3 %) 0 (0 %) 1 (0.3 %)
Benign breast lesion with atypia 1 (0.3 %) 0 (0 %) 1 (0.3 %)
Benign proliferative breast disease 1 (0.3 %) 0 (0 %) 1 (0.3 %)
B. Non-neoplastic  
Gynecomastia 0 (0 %) 33 (82.5 %) 33 (8.5 %)
Galactocele 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Fat necrosis 12 (3.4 %) 0 (0 %) 12 (3.1 %)
Breast abscess 9 (2.6 %) 0 (0 %) 9 (2.3 %)
Inflammatory breast lesion 9 (2.6 %) 1 (2.5 %) 10 (2.6 %)
Mammary duct ectasia 8 (2.3 %) 0 (0 %) 8 (2.1 %)
Acute mastitis 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Cystic breast mass 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Granulomatous mastitis 3 (0.9 %) 0 (0 %) 3 (0.8 %)
Breast ulcer 1 (0.3 %) 0 (0 %) 1 (0.3 %)